Jane Street Group, LLC Immunovant, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 68,500 shares of IMVT stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,500
Previous 140,317 51.18%
Holding current value
$1.88 Million
Previous $3.7 Million 49.14%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$27.51 - $27.51 $5.06 Million - $5.06 Million
183,848 Added 131.02%
324,165 $8.92 Million
Q2 2024

Aug 14, 2024
BUY
$25.1 - $31.61 $1.83 Million - $2.3 Million
72,712 Added 107.55%
140,317 $3.7 Million
Q1 2024

May 15, 2024
SELL
$30.27 - $43.79 $16.5 Million - $23.9 Million
-546,736 Reduced 89.0%
67,605 $2.18 Million
Q4 2023

Feb 14, 2024
BUY
$31.31 - $44.19 $8.95 Million - $12.6 Million
285,829 Added 87.01%
614,341 $25.9 Million
Q3 2023

Nov 14, 2023
BUY
$18.55 - $39.96 $3.11 Million - $6.69 Million
167,466 Added 103.99%
328,512 $12.6 Million
Q2 2023

Aug 14, 2023
BUY
$14.2 - $23.75 $903,460 - $1.51 Million
63,624 Added 65.31%
161,046 $3.06 Million
Q1 2023

May 15, 2023
SELL
$15.27 - $19.72 $3.38 Million - $4.37 Million
-221,649 Reduced 69.47%
97,422 $1.51 Million
Q4 2022

Feb 14, 2023
BUY
$6.59 - $17.75 $2 Million - $5.38 Million
302,965 Added 1881.07%
319,071 $5.66 Million
Q3 2022

Nov 14, 2022
BUY
$3.93 - $6.37 $63,296 - $102,595
16,106 New
16,106 $90,000
Q2 2022

Aug 16, 2022
SELL
$3.38 - $5.65 $139,181 - $232,655
-41,178 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$5.06 - $8.77 $47,685 - $82,648
9,424 Added 29.68%
41,178 $226,000
Q4 2021

Feb 15, 2022
SELL
$7.33 - $9.32 $344,524 - $438,058
-47,002 Reduced 59.68%
31,754 $270,000
Q3 2021

Nov 16, 2021
SELL
$7.01 - $11.37 $273,123 - $442,997
-38,962 Reduced 33.1%
78,756 $684,000
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $979,216 - $1.76 Million
104,172 Added 769.02%
117,718 $1.24 Million
Q1 2021

May 18, 2021
BUY
$13.08 - $49.6 $177,181 - $671,881
13,546 New
13,546 $217,000
Q4 2020

Feb 17, 2021
SELL
$36.36 - $52.71 $534,964 - $775,522
-14,713 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$22.61 - $38.9 $262,456 - $451,551
-11,608 Reduced 44.1%
14,713 $518,000
Q2 2020

Aug 17, 2020
BUY
$13.87 - $28.44 $198,770 - $407,573
14,331 Added 119.52%
26,321 $640,000
Q1 2020

May 15, 2020
BUY
$8.36 - $17.13 $100,236 - $205,388
11,990 New
11,990 $186,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email